Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Editorial: Subduing Lupus: Can Preclinical Autoimmune Disease Be Arrested?

Literature DB >> 27390125

Editorial: Subduing Lupus: Can Preclinical Autoimmune Disease Be Arrested?

Heather M Berens-Norman¹, Susan A Boackle².

Abstract

Entities: Disease Gene Species

Mesh：

Year: 2016 PMID： 27390125 PMCID： PMC5042838 DOI： 10.1002/art.39804

Source DB: PubMed Journal: Arthritis Rheumatol ISSN： 2326-5191 Impact factor: 10.995

× No keyword cloud information.

12 in total

1. Altered Th17 cells and Th17/regulatory T-cell ratios indicate the subsequent conversion from undifferentiated connective tissue disease to definitive systemic autoimmune disorders.

Authors: Peter Szodoray; Britt Nakken; Sandor Barath; Istvan Csipo; Gabor Nagy; Fadi El-Hage; Liv T Osnes; Gyula Szegedi; Edit Bodolay
Journal: Hum Immunol Date: 2013-08-20 Impact factor: 2.850

2. Peroxisome proliferator-activated receptor gamma agonists in the prevention and treatment of murine systemic lupus erythematosus.

Authors: Tamar R Aprahamian; Ramon G Bonegio; Zachary Weitzner; Raffi Gharakhanian; Ian R Rifkin
Journal: Immunology Date: 2014-07 Impact factor: 7.397

Review 3. Using genetics to deliver personalized SLE therapy-a realistic prospect?

Authors: Benjamin Rhodes; Timothy J Vyse
Journal: Nat Rev Rheumatol Date: 2010-05-04 Impact factor: 20.543

Review 4. Preclinical lupus.

Authors: Rebecka Bourn; Judith A James
Journal: Curr Opin Rheumatol Date: 2015-09 Impact factor: 5.006

5. Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation.

Authors: Cristiana E Juge-Aubry; Emmanuel Somm; Vittorio Giusti; Agnès Pernin; Rachel Chicheportiche; Chantal Verdumo; Françoise Rohner-Jeanrenaud; Danielle Burger; Jean-Michel Dayer; Christoph A Meier
Journal: Diabetes Date: 2003-05 Impact factor: 9.461

6. Normalization of CD4+ T cell metabolism reverses lupus.

Authors: Yiming Yin; Seung-Chul Choi; Zhiwei Xu; Daniel J Perry; Howard Seay; Byron P Croker; Eric S Sobel; Todd M Brusko; Laurence Morel
Journal: Sci Transl Med Date: 2015-02-11 Impact factor: 17.956

7. Interferon signature gene expression is correlated with autoantibody profiles in patients with incomplete lupus syndromes.

Authors: Q-Z Li; J Zhou; Y Lian; B Zhang; V K Branch; F Carr-Johnson; D R Karp; C Mohan; E K Wakeland; N J Olsen
Journal: Clin Exp Immunol Date: 2009-12-01 Impact factor: 4.330

Editorial: Subduing Lupus: Can Preclinical Autoimmune Disease Be Arrested?

1. Altered Th17 cells and Th17/regulatory T-cell ratios indicate the subsequent conversion from undifferentiated connective tissue disease to definitive systemic autoimmune disorders.

2. Peroxisome proliferator-activated receptor gamma agonists in the prevention and treatment of murine systemic lupus erythematosus.

Review 3. Using genetics to deliver personalized SLE therapy-a realistic prospect?

Review 4. Preclinical lupus.

5. Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation.

6. Normalization of CD4+ T cell metabolism reverses lupus.

7. Interferon signature gene expression is correlated with autoantibody profiles in patients with incomplete lupus syndromes.

8. Discovery of biomarkers for systemic lupus erythematosus using a library of synthetic autoantigen surrogates.

9. Risk factors for ANA positivity in healthy persons.

10. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data.

Review 1. The impact of anti-U1-RNP positivity: systemic lupus erythematosus versus mixed connective tissue disease.

2. SLE: reconciling heterogeneity.